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Abstract: Although many studies have investigated the overlap between pain phenotypes and
chronic fatigue syndrome (CFS) in adults, little is known about the relationship between these con-
ditions in adolescents. The study’s aim was therefore to identify whether a relationship exists be-
tween chronic widespread pain (CWP) and CFS in adolescents and investigate whether the two
share common associations with a set of covariates. A questionnaire was administered to offspring
of the Avon Longitudinal Study of Parents and Children (ALSPAC) at age 17, asking about site, dura-
tion, and pain intensity, from which participants with CWP were identified. At the same research
clinic, a computer-based Revised Clinical Interview Schedule was filled out, fromwhich a classification
of CFS was obtained. The relationship between selected covariates and CFS and CWP was investi-
gated using a variety of logistic, ordinal logistic, and multinomial regressions. We identified 3,214 ad-
olescents with complete data for all outcomes and covariates. There were 82 (2.6%) individuals
classified as CFS and 145 (4.5%) as CWP. A classification of CFS resulted in an increased likelihood
of having CWP (odds ratio = 3.87; 95% confidence interval, 2.05–7.31). Female adolescents were
approximately twice as likely to have CFS or CWP, with multinomial regression revealing a greater
sex effect for CWP compared with CFS. Those with exclusive CFS were more likely to report higher
levels of pain and greater effect of pain compared with those without CFS, although associations
attenuated to the null after adjustment for covariates, which did not occur in those with exclusive
CWP. Multinomial regression revealed that relative to having neither CFS nor CWP, a 1-unit increase
in the depression and anxiety scales increased the risk of having exclusive CFS and, to a greater
extent, the risk of having comorbid CFS and CWP, but not exclusive CWP, which was only related
to anxiety.
Perspective: In this cohort, 14.6% of adolescents with CFS have comorbid CWP. The likely greater
proportion of more mild cases observed in this epidemiological study means that prevalence of over-
lap may be underestimated compared with those attending specialist services. Clinicians should be
aware of the overlap between the 2 conditions and carefully consider treatment options offered.
ª 2016 The Authors. Published by Elsevier Inc. on behalf of the American Pain Society. This is an open
access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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P
ain is a common comorbidity in adults with chronic
fatigue syndrome (CFS; also termedmyalgic enceph-
alomyelitis). Indeed, 5 of the 8 and 4 of the 12
accompanying symptoms required to diagnose CFS ac-
cording to the Centers for Disease Control and Preven-
tion and National Institute for Health and Care
Excellence (NICE) criteria respectively, reflect pain25,39
(see Supplementary File 1 for the diagnostic criteria
used for the classification of CFS and fibromyalgia).
Acknowledging this overlap between CFS and pain phe-
notypes (eg, fibromyalgia, chronic widespread pain
[CWP], chronic regional pain), there is phenotypic varia-
tion between the sets of conditions, with notable
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immunological55,56 and autonomic37 differences
observed between the two, as well as discordant pat-
terns of brain activity.18,59
Understanding the epidemiology of CFS and the over-
lap with pain phenotypes (eg, CWP) is important to
develop treatment approaches for those with CFS as
well as severe pain.41 The presence of severe pain in
adults with CFS is associated with a worse outcome with
cognitive-behavioral therapy11,29 suggesting a specific
intervention to target pain may improve outcome in
this group.41 However, without proper understanding
of the relatedness of these conditions, this often coming
via large epidemiological studies, designing an effective
intervention study is difficult.
Adolescents with CFS have levels of pain similar to that
of adults with CFS.16 Twenty percent of adolescents with
CFS experience severe pain (>75 of 100 on the visual
analog scale).16 Compared with control participants,
they report lower pressure pain thresholds,61 a greater
pain severity, and a greater effect of pain, with the great-
est effect occurring at school and for ‘general activity.’68
Although there is much literature on the relationship be-
tween CFS and pain phenotypes in adults,1,10,42,71 little is
known about adolescent populations, or the overlap
between the 2 conditions.40,47,52,70
This study aimed to investigate the relationship be-
tween one of these pain phenotypes, CWP, and CFS in ad-
olescents. In particular, we aimed to describe the
similarities and differences between CWP and CFS,
examine the prevalence of the co-occurrence of these 2
conditions, understand how a classification of CFS or
CWP affects the interpretation of the effects of pain
(pain intensity, pain interference, and change in
behavior), and investigate the association between these
and other comorbidities (eg, depression, anxiety, and
obesity). Understanding the relationship between and
CFS and CWP is important in itself, but any finding could
also have relevant implications for juvenile fibromyalgia
(because the2 conditions share similar diagnostic criteria:
pain at multiple affected sites, lasting longer than
3 months, and of high intensity).35,50,54 The diagnostic
criterion for fibromyalgia also includes localized areas
of tenderness, which is not included in the CWP
diagnosis.
We have previously shown in a large United Kingdom
birth cohort, that the prevalence of CFS during adoles-
cence increases from approximately 1.47%22 at 13 years
to 2.99% at 18 years (Norris, 2016 unpublished data).
Within the same cohort, we have also examined the prev-
alenceofmusculoskeletalpainphenotypesduringadoles-
cence and found that the prevalence of chronic regional
pain and CWP at aged 17 years was 4.7% and 4.3%,
respectively (n = 3,376).23 Our hypothesis was that CFS
and CWP would share common associations, on the basis
of findings from separate studies that have revealed com-
mon covariates (eg, obesity,23,43,44 depression,4,7
anxiety,27,66 socioeconomic status,5,22 and female
sex5,13,15,22,67) associated with CFS as well as various pain
phenotypes, including CWP. To the authors’ knowledge,
no study in adolescence has sought to compare those
experiencing exclusive CFS, exclusive CWP, or both, and
identify covariates for these conditions, in the same
population. As such, we sought to investigate the
relationship between CWP and CFS and a range of
covariates, after taking into account the overlap which
exists between the two, within a sample of adolescents
participating in the Avon Longitudinal Study of Parents
and Children (ALSPAC).
Methods
Study Population
The ALSPAC is a geographically based United Kingdom
cohort that recruited pregnant women living in the
former county of Avon (Southwest England) with an ex-
pecteddeliverydateofApril 1, 1991 through toDecember
31, 1992.8 A total of 14,541 pregnant women were
enrolled with 14,062 children born. The children have
been followed-up regularly since birth with postal ques-
tionnaires for children and their parents, clinical assess-
ments, and the collection of biological samples (please
note that the study Web site contains details of all the
data thatareavailable througha fully searchabledatadic-
tionary: www.bris.ac.uk/alspac/researchers/data-access/
data-dictionary/). This study is on the basis of the individ-
uals who completed the pain questionnaire and the
computer-based clinical interview at the age 17 research
clinic (n = 5,217). Response rates for the assessments
from 4 weeks to 18 years have been described.8 The AL-
SPACaims to increase the completeness ofdataandbetter
characterize nonresponders using data linkage to
routinely collected data sources, which will also provide
further insights into participation biases.8 Ethical
approval was obtained from the ALSPAC Law and Ethics
Committee. Parental consent and child’s assent was ob-
tained for all measures.
Pain Questionnaire
A structured pain questionnaire was administered at
the 17-year clinic (mean age at attendance 17 years,
10 months), assembled from domains and scales previ-
ously validated in United Kingdom populations.23 It
was given to all participants that attended the 17-year
clinic where it was completed on the day of attendance,
or returned by post if this was not possible. Participants
were asked to shade in the site of pain they had on a
manikin and indicate whether the pain had started
within the past 3 months or more than 3 months ago
(maximum 6 months ago).32 CWP was comprised of
pain longer than 3 months in duration, axial pain, and
upper right quadrant pain plus lower left quadrant
pain, or upper left quadrant pain plus lower right quad-
rant pain, assessed according to the shading of the pain
manikin by the participants.23 This variable was on the
basis of the diagnostic criteria for fibromyalgia of pain
on both sides of the body, above and below the waist,
and in the axial skeleton, which has been present for
3 months or longer. The diagnostic criterion for fibromy-
algia also includes localized areas of tenderness, which
were not assessed on the pain questionnaire. Separate
to the questions contributing to the classification of
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CWP, participants were asked about headaches and
abdominal pain during the pastmonth on a troublesome
scale ranging from no pain, not at all troublesome,
slightly troublesome, moderately troublesome, very
troublesome, to extremely troublesome.46
The pain questionnaire also assessed the participants’
experience of pain on a 1 to 10 to scalewhere 1was equal
to ‘‘no pain’’ and 10 was equal to ‘‘pain as bad as could
be.’’ The questions included how intense was the worst
pain in the past 6 months and how intense was the
pain on average in the past 6 months. A similar 1 to 10
scale was used to assess how much their pain had inter-
fered with daily activities in the past 6 months and how
their pain has changed their ability to take part in recre-
ational, social, and family activities (disruption to social
activities).65
CFS
At the same clinic, participants completed a computer-
based Revised Clinical Interview Schedule (CIS-R).30 We
used established criteria39 to define CFS. Participants
needed to be disabled by their fatigue, to have fatigue
that lasted >6 months, and required 1 additional symp-
tom. In addition, we excluded those with other explana-
tions for their fatigue.
Participants were classified as CFS if they indicated that
they had been getting tired or had been lacking in en-
ergy during the past month and then responded ‘yes’
to >2 of the following 4 items: 1) felt tired or lacking in
energy for 4 days or more in the past 7 days, 2) felt tired
or lacking in energy for more than 3 hours in total on any
day in the past 7 days, 3) felt so tired or lacking in energy
that they had to push themselves to get things done on 1
or more occasion in the past 7 days, and 4) felt tired or
lacking in energy when doing things they enjoy in the
past 7 days. Participants were classified as not chronically
fatigued if: the tiredness or lack of energy had lasted for
<6months, the adolescent thought it was due to exercise
or medication, the adolescent felt better after resting, if
daily activities were not impaired, or if exercise did not
make them feel exhausted the following day. The CIS-R
also provided data on 9 of the 12 associated symptoms
of CFS listed in NICE guidelines,39 namely: muscle or joint
pain, headaches, painful glands, sore throat, problems
with memory or concentration (cognitive dysfunction),
dizziness, nausea, and insomnia (as part of the ‘difficulty
sleeping’ symptom in the NICE guideline). Adolescents
without any of these accompanying symptoms were re-
classified as non-CFS. Because data on only 9 of the 12
symptoms included in the NICE guideline could be
collected using the CIS-R, the estimates of CFS at 17 years
are likely to be conservative (ie, an adolescent may have
been classified as non-CFS because of the lack of 1 of the
9 symptoms, but he/she may have had 1 of the other 3
symptoms for which data were uncollected). Of those
identified as having CFS, 16.5% had a single symptom,
29.13% had 2, 25.54% had 3, 10.68% had 4, 8.74% had
5, 5.83% had 6, 2.91% had 7, and .97% had 8. Adoles-
cents were classified as non-CFS if they reported having
had problems with alcohol or drugs (crack, solvents,
heroin, or cocaine) during the previous year, or a diag-
nosis of anorexia nervosa.
Covariates
We chosemeasures known to be associatedwith either
CFS or CWP.7,15,17,21-23 Depression and anxiety were
assessedusing theCIS-R,30 a self-administered, computer-
ized interview completed at age 17 at the research clinic.
The CIS-R is adapted from the Clinical Interview Schedule
to allow lay interviewers to assess psychiatricmorbidity in
the community. It is a valid instrument for the detection
of a range of common mental disorders in various coun-
tries31,48,49 although in the United Kingdom, although
demonstrating acceptable levels of specificity (.94, 95%
confidence interval [CI] = .90–.97), levels of sensitivity
are less favorable (.31; 95% CI = .09–.61).9
The CIS-R includes 14 sections establishing the severity
of different symptom clusters: somatic symptoms, fatigue,
concentration, sleep, irritability, worries over physical
health, depression, depressive ideas, worry, anxiety, pho-
bias, panic, compulsions, andobsessions. Initial filter ques-
tions in each section establish the existence of a particular
symptom in the previous month, leading to a more
detailed assessment focusing on the past week. For the
assessment of anxiety anddepression,weused the specific
anxiety (5 questions) and depression (4 questions) sub-
scales, both of which are scored from 0 (least severe) to
4 (most severe) depending on the symptom’s frequency
and severity. Height was measured to the last complete
millimeter using a Harpenden stadiometer (Holtain
Limited, Crymych, Dyfed, United Kingdom). Weight was
measured to the nearest 50 g with a Tanita Body Fat
Analyzer (Tanita Corp, Tokyo, Japan). Body mass index
(BMI) was derived from clinic-measured height and
weight (weight [kg]/height [m2]). Classifications of under-
weight, recommended weight, overweight, and obesity
were produced in accordance with the International
Obesity Task Force cutoffs.14Mothers’ highest educational
qualification was used as a proxy for socioeconomic sta-
tus.26 Thiswas assessed at 32weeks’ gestation and catego-
rized as none/minimal formal qualification, vocational
qualification, O level (General Certificate of Education:
Ordinary Level), A level (General Certificate of Education:
Advanced Level), and university degree.
Statistical Methods
Data used in the analyses were on the basis of those
who had completed the pain questionnaire and CIS-R
and had complete data for sex, maternal education,
and BMI. The participants were categorized according
to their pain/fatigue status; those with neither, those
with exclusive CFS, those with exclusive CWP, and those
with CWP as well as CFS. These categories were
compared against the other variables using chi-squared
testing (with Fisher exact test used where appropriate).
The relationship between CFS and CWP with our chosen
covariates was assessed using logistic regression, using a
crudemodel and an adjustedmodel, to calculate odds ra-
tios (ORs) and 95% CIs. In cases in which the covariate
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hadmore than 2 categories the appropriate use of a com-
mon OR was assessed using likelihood ratio testing.
The relationship between CFS and the severity of pain
experienced was tested using ordered logistic regression
in crude and adjusted models. Although the original
pain rating variable was an ordinal 1 to 10 scale these
data were collapsed into a 4-category outcome for ease
of analysis; no pain (1 of 10), a score of 2 (5 of 10), a score
of 6 (9 of 10), and a score of 10 (10 of 10). The propor-
tional odds assumption was examined using a likelihood
ratio test for each pain rating outcome. Finally the asso-
ciations between pain/fatigue status and our covariates
were examined using multinomial logistic regression,
which provides a relative risk ratio (RRR) for each factor
comparative to our reference category of neither CFS
nor CWP. All statistical analyses were conducted using
Stata 13.1 (Stata Corp, College Station, TX).
Results
Of13,978 children alive at 1 year, 5,217 attended the 17-
year research clinic. Of these, 4,001 (76.7%) completed the
pain questionnaire and 4,564 (87.5%) completed the
CIS-R session. There were 3,214 adolescents (61.6%) with
complete data for all outcomes and covariates. Of these
individuals, 1,349 were male (42.0%). The average age
of the participants at the time of clinic attendance was
17.8 years (SD = .4). Compared with the complete cohort,
those included in the current study were more likely to
have mothers educated to at least degree level (20.3%
vs 10.2%) and who gave birth at a later age (29.4 years
vs 27.5 years). Compared with those with complete data,
those who only had pain data did not have different rat-
ings of pain: at the current time, at its worst, or ratings of
disruption of activities from pain. However, the sample
with only pain data did have a higher proportion of ado-
lescents reporting the highest rating of pain on average
(2.15% vs 1.84%, P = .002). There were no differences in
levels of fatigue, depressive, or anxiety symptoms in those
with complete data versus those who only had data from
the CIS-R session.
There were 82 individuals (2.6%) classified with CFS
and 145 (4.5%) with CWP. There were 12 individuals
(.4%) who were classified with both, corresponding to
an overlap of 14.6%of thosewith CFS also having comor-
bid CWP.
Table 1 shows descriptive statistics for those with exclu-
sive CFS and exclusive CWPon the basis of thosewith com-
plete data for CFS, CWP, maternal education, and BMI (it
was decided not to present data for those with CFS
together with CWP because the sample was small and
cross-tabulations with covariates could potentially lead
to disclosure of participants). CFS and CWP were more
common in female participants, despite only representing
58% of the sample; the proportion of those classified as
CFS and CWP who were female was 74.3% and 72.9%,
respectively. Those reporting moderate headaches had a
higher prevalence of exclusive CFS and exclusive CWP,
compared with those not reportingmoderate headaches.
The same was apparent for moderate abdominal pain.
Thereweredifferences in the prevalence of the conditions
across levels of anxiety and depression, with higher levels
of anxiety or depression being associated with higher
prevalence of the condition (except for depression and
CWP). Data for those with CFS together with CWP are
omitted from Table 1 because of low cell counts, which
could potentially lead to issues of deductive disclosure.
However, associations similar to those reported for exclu-
sive CFS and exclusive CWP were observed for this group
(ie, no association with maternal education or BMI cate-
gory, but greater prevalence in those reporting moderate
headaches, abdominal pain, and in those with higher
levels of anxiety and depression).
Associated Factors With CFS and CWP
CFS
Unadjusted estimates reveal that female participants
had more than twice the risk of being classified as CFS
(OR = 2.14, 95% CI = 1.30–3.53). A 1-unit increase in the
depression and anxiety scales resulted in an increase in
odds in the magnitude of 2.47 (95% CI = 2.21–2.86) and
2.50 (95% CI = 2.14–2.90), respectively.
Table 1. Descriptive Statistics
COVARIATE N
EXCLUSIVE
CFS (N = 70)
EXCLUSIVE
CWP (N = 133)
N (%) P N (%) P
Sex
Male 1349 18 (1.3) .005 36 (2.7) <.001
Female 1865 52 (2.8) 97 (5.2)
Maternal education
CSE or vocational 593 9 (1.52) .191 26 (4.38) .768
O level 1071 25 (2.3) 43 (4.0)
A level 899 26 (2.9) 41 (4.6)
Degree 651 10 (1.5) 23 (3.5)
BMI category (IOTF)
Underweight 242 8 (3.0) .282 6 (2.5) .306
Recommended 2256 51 (2.3) 92 (4.0)
Overweight 502 6 (1.2) 22 (4.4)
Obese 214 5 (2.4) 13 (6.1)
At least moderate headaches
No 2748 45 (1.6) <.001 89 (3.2) <.001
Yes 466 25 (5.4) 44 (9.4)
At least moderate abdominal pain
No 2840 48 (1.7) <.001 79 (2.8) <.001
Yes 374 22 (5.9) 54 (14.4)
Anxiety score
0 2698 28 (1.0) <.001 99 (3.7) .006
1 273 12 (4.4) 14 (5.1)
2 132 11 (8.3) 11 (8.3)
$3 111 19 (17.12) 9 (8.11)
Depression score
0 2539 22 (.9) <.001 95 (3.7) .108
1 354 15 (4.2) 17 (4.8)
2 169 8 (4.7) 11 (6.5)
$3 152 25 (16.45) 10 (6.58)
Abbreviations: CSE, Certificate of Secondary Education; O level, General Certifi-
cate of Education: Ordinary Level; A level, General Certificate of Education:
Advanced Level; IOTF, International Obesity Task Force.
NOTE. N on the basis of complete data availability for pain, fatigue, and covari-
ates. P on the basis of c2 test for comparison of CFS and CWP (separately),
with the total sample.
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Table 2 shows that the associations with anxiety
(OR = 1.72, 95% CI = 1.42–2.08) and depression
(OR = 1.87, 95% CI = 1.56–2.25) were attenuated after
adjustment for obesity and maternal education.
CWP
In the unadjusted models, female participants had
twice the odds receiving a classification of CWP
compared with male participants (OR = 2.02, 95%
CI = 1.39–2.94). A 1-unit increase in the depression and
anxiety scales was once again associated with an
increased odds of CWP (OR = 1.40, 95% CI = 1.22–1.62
and OR = 1.53, 95% CI = 1.32–1.78). Adjusting for obesity
and maternal education resulted in a weakened associa-
tion with anxiety and no association with depression.
The OR between CFS and CWP revealed that a classifi-
cation of 1 (vs no classification) was associated with
387% higher odds of receiving a classification of the
other (OR = 3.87, 95% CI = 2.05–7.31), such that those
with a classification of CFS were approximately 4 times
more likely to be classified as having CWP, compared
with those not classified as CFS. However, after adjust-
ment for the covariates, the strength of evidence for
this association attenuated to the null (OR = 1.92, 95%
CI = .91–4.06).
Relationship Between CFS and CWP and
the Experience of Pain
Table 3 shows the crude and adjusted associations be-
tween the presence of exclusive CFS and exclusive CWP
and the ratings of pain (at its worst and on average),
its interference in daily life, and its effect on disruption
to social activities. Unadjusted estimates reveal that
compared with not being classified as having exclusive
CFS, those with exclusive CFS were more likely to report
a higher category of average pain over the past 6months
(OR = 2.17, 95%CI = 1.21–3.92). The presence of exclusive
CFS produced an OR of 3.50 (95% CI = 2.02–6.09) for re-
porting a higher category of pain-related daily interfer-
ence, compared with not having exclusive CFS. Finally,
compared with those without CFS, the OR of reporting
a higher category of disruption to social activities as a
result of their pain was 2.23 (95% CI = 1.28–3.88) for
those who were classified as having exclusive CFS. After
adjustment for covariates, only the association between
exclusive CFS and daily interference as a result of pain re-
mained (OR = 2.19, 95% CI = 1.24–3.88).
Unadjusted estimates in those with exclusive CWP (vs
not) were more than 2.5 times more likely to report a
higher category of pain when at its most intense
(OR = 2.58, 95% CI = 1.78–3.74), with a similar likelihood
to report a higher category of average pain. A higher
level of pain- related daily interference (OR = 1.84, 95%
CI = 1.30–2.60) and a higher category of disruption to so-
cial activities as a result of their pain (OR = 1.58, 95%
CI = 1.13–2.22), was also reported in those with exclusive
CWP; interestingly, these estimates were lower than
those reported in those with exclusive CFS. These associ-
ations remained with minimal attenuation after adjust-
ment for the covariates.
Associated Factors With Exclusive CFS,
Exclusive CWP, and Comorbid CFS and
CWP
Table 4 describes the relationship between exclusive
CFS, exclusive CWP, the 2 conditions occurring together,
and obesity, maternal education, depression, and anxi-
ety (all relative to having neither of the conditions). As
the RRRs reveal, a 1-unit increase in the depression and
anxiety scales was associated with greater risk of being
classified as having exclusive CFS, compared with neither
CFS or CWP (RRR = 1.83, 95% CI = 1.50–2.22; RRR = 1.75,
95% CI = 1.43–2.15, respectively), with the other vari-
ables in the model held constant. Female sex (relative
to male sex) was associated with a greater likelihood of
being classified as having exclusive CWP, as opposed to
having neither of the conditions (RRR = 1.87; 95%
CI = 1.26–2.77). This was also true for increasing levels
of anxiety (RRR = 1.34, 95% CI = 1.10–1.63), but with
no association between depression and exclusive CWP.
Table 2. Logistic Regression Showing Odds of CFS and CWP
OUTCOME COVARIATE
CRUDE MULTIVARIABLE
OR 95% CI P OR 95% CI P
CFS CWP versus no CWP 3.87 2.05–7.31 <.001 1.92 .91–4.06 .086
Female versus male 2.14 1.30–3.53 .003 1.29 .75–2.21 .353
Obesity versus non-obese .91 .36–2.27 .837 .82 .32–2.15 .682
Maternal education 1.07 .89–1.29 .445 1.12 .92–1.37 .262
Depression score 2.47 2.12–2.86 <.001 1.87 1.56–2.25 <.001
Anxiety score 2.50 2.14–2.90 <.001 1.72 1.42–2.08 <.001
CWP CFS versus no CFS 3.87 2.05–7.31 <.001 1.98 .97–4.04 .059
Female versus male 2.02 1.39–2.94 <.001 1.79 1.22–2.62 .003
Obesity versus nonobese 1.41 .78–2.53 .256 1.35 .74–2.46 .327
Maternal education 1.00 .88–1.15 .951 1.03 .89–1.18 .712
Depression score 1.40 1.22–1.62 <.001 1.14 .95–1.36 .155
Anxiety score 1.53 1.32–1.78 <.001 1.32 1.10–1.58 .003
NOTE. N = 3214. OR represents odds of outcome per unit increase in covariate. Adjusted model includes adjustment for sex, obesity, maternal education, depression
score, anxiety score, and mutual adjustment for CWP/CFS.
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Increasing levels of depression and anxiety resulted in a
greater likelihood of being classified as having comorbid
CFS and CWP relative to having neither of the conditions
(RRR = 2.41, 95% CI = 1.51–3.84; RRR = 2.04, 95%
CI = 1.30–3.21, respectively).
Discussion
Summary of Findings
To our knowledge, this is the first population-based
study to present prevalence rates of CFS, CWP, and the
prevalence of overlap between these 2 conditions in
adolescence. In addition, we examined similarities and
differences in pain variables among these conditions,
as well as covariates such as obesity, depression, and
anxiety.
In this cohort, 14.6% of those with CFS also experi-
enced CWP. Unsurprisingly therefore, the presence of 1
of the conditions had a strong predictive effect for the
presence of the other condition (OR = 3.87, 95%
CI = 2.05–7.31). Female participants were approximately
twice as likely to have CFS or CWP, although this sex ef-
fect was attenuated after adjustment for obesity and
maternal education and CWP or CFS. Those with CFS
were more likely to report a higher level of pain and
greater effect of such pain compared with those without
CFS. Multinomial regression revealed that relative to
having neither CFS nor CWP, a 1-unit increase in the
depression and anxiety scales increased the risk of having
exclusive CFS and, to a greater extent, the risk of having
comorbid CFS and CWP, whereas only anxiety (not
depression) showed an association with exclusive CWP.
Female participants had a greater risk of having exclusive
CWP (relative to having neither) and interestingly, this
risk was greater and supported more strongly than for
the female risk for exclusive CFS and both conditions
co-occurring. We did not find an association between
obesity or maternal education with either exclusive CFS
or CWP.
Comparison With Other Studies
In a study of adolescents with CFS versus healthy con-
trol participants,68 it was reported that, similar to this
study, adolescents with CFS had higher self-reported
pain severity and pain interference scores. However, un-
like in this study, adjustment for depression and anxiety
was not made and thus the authors were unable to
rule out the likely influence of confounding on these as-
sociations. It has been hypothesized that the increased
sensitivity to pain in those with CFS51,53 could be a
result of a general state of hypersensitivity33 with a re-
sulting hyperalgesia phenotype.34 For example, those
with CFS have also been reported to have lower thresh-
olds to thermal and electrical stimuli.60,62 This central
sensitization hypothesis has also been implicated in the
pathogenesis of CWP33 and fibromyalgia.69 Interestingly,
when comparing the ratings of pain and interference in
those with exclusive CFS versus exclusive CWP, we
observed no differences, however, as Table 3 shows, all
of the associations between the presence of CWP and
ratings of pain and interference remained after adjust-
ment for covariates, whereas in the case of exclusive
Table 4. Multinomial Regression Examining the
Relationship Between CWP and CFS
OUTCOME COVARIATE RRR 95% CI P
Neither* — Reference category
Exclusive CFS Female (vs male) 1.44 .81–2.54 .212
Obesity (vs nonobese) .95 .36–2.50 .910
Maternal education 1.09 .88–1.35 .413
Depression 1.83 1.50–2.22 <.001
Anxiety 1.75 1.43–2.15 <.001
Exclusive CWP Female (vs male) 1.87 1.26–2.77 .002
Obesity (vs nonobese) 1.46 .80–2.66 .218
Maternal education 1.01 .87–1.17 .907
Depression 1.11 .92–1.35 .279
Anxiety 1.34 1.10–1.63 .004
Bothy Female (vs male) 1.12 .28–4.47 .873
Obesity (vs nonobese) — — —
Maternal education 1.50 .86–2.61 .153
Depression 2.41 1.51–3.84 <.001
Anxiety 2.04 1.30–3.21 .002
NOTE. N = 3214. For RRR, for a 1-unit increase in covariate comparative to the
reference group, calculated by exponentiating the relative log odds. Results blank
where there were no cases of obesity.
*Neither represents those that had neither CWP nor CFS.
yIndividuals who had CWP and chronic disabling fatigue.
Table 3. Ordered Logistic Regression Examining the Relationship Between CFS and Rating of Pain
PAIN RATING IN PAST 6 Mo N
CRUDE MULTIVARIABLE
OR 95% CI P OR 95% CI P
Exclusive CFS At worst 1483 1.82 .99–3.35 .055 1.18 .33–2.23 .599
On average 1469 2.17 1.21–3.92 .010 1.49 .80–2.80 .204
Daily interference 1533 3.50 2.02–6.09 <.001 2.19 1.24–3.88 .007
Disruption to social activities 1501 2.23 1.28–3.88 .004 1.40 .79–2.48 .247
Exclusive CWP At worst 1483 2.58 1.78–3.74 <.001 2.39 1.65–3.48 <.001
On average 1469 2.42 1.70–3.44 <.001 2.23 1.55–3.21 <.001
Daily interference 1533 1.84 1.30–2.60 .010 1.72 1.21–2.44 .001
Disruption to social activities 1501 1.58 1.13–2.22 .008 1.53 1.06–2.12 .021
NOTE. n indicates those with complete data for all covariates. Adjusted model adjusted for sex, obesity, maternal education, anxiety score and depression score. OR
represents odds of those with exclusive CFS or exclusive CWP being in a higher category of pain rating than those without CFS or CWP, respectively.
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CFS, only the association with daily interference re-
mained after adjustment, which may suggest that these
covariates play a greater role in the manifestation of
pain in those with CFS versus CWP.
In this study, although higher levels of depression and
anxiety scores remained associated with exclusive CFS,
only anxiety appeared to be related to exclusive CWP.
Although depression and anxiety have been strongly
and consistently associated with CFS and fibromyalgia,
most study designs have made it impossible to separate
the possible influence of an overlapping CFS/fibromyal-
gia comorbidity. Indeed the results from themultinomial
regression are in contrast to the results from the logistic
regression in which CFS and CWP were not separated,
and which resulted in the presence of an association be-
tween CWP and depression scores (Table 2). It can be
speculated therefore, that this association was actually
driven by the relationship between depression and the
comorbid CFS. In our study, increasing levels of anxiety
and depression were more strongly associated with the
presence of CFS and CWP together, than the 2 conditions
independently, which may be a consequence of the
greater morbidity.
Female participants were more likely to be classified as
CFS,which is in linewithprevious estimates in this cohort,
at this age (Norris, 2016 unpublished data) and earlier in
adolescence.15 We also observed an increased risk of
exclusive CWP in female compared with male partici-
pants, which is in line with previous reports of the condi-
tion13 and of fibromyalgia.2,22,27,32,69 It is of interest that
this female-associated risk for exclusive CWP was of
greater severity and strength than for exclusive CFS.
This greater disparity in the female:male ratio observed
for CWPhas alsobeenobserved forfibromyalgia. Howev-
er, it has been speculated that this sex disparity in fibro-
myalgia is a consequence of the previous American
College of Rheumatology criteria,68,70 which required
the presence of 11 of 18 tender points, a finding that
occurs much more commonly in women.66,69 Because
the tender points criteria is not included in the CWP
diagnosis, this phenomenon cannot be explaining the
increased prevalence of CWP in female compared to
male participants. We are not certain as to the reason
behind this increased prevalence of CWP in female
participants, but studies have attributed the increased
risk observed in women to various factors, including the
differential effects of the gonadal hormones,2,3,20,45
differences in endogenous pain modulation,19,24 and
divergent ‘gender’ roles.6,36
In this study, obesity was found to have little effect on
either exclusive CFS or CWP. The lack of an effect of
obesity on CWP has been observed previously in this
cohort, with Deere et al reporting no effect of obesity
on the presence of CWP but using a different classifica-
tion of obesity.23 However, they did find an association
between obesity and other pain phenotypes. Studies
investigating the relationship between obesity and CFS
have also reported a lack of association in young peo-
ple63 and adults.12 The current study is unique, however,
in that, unlike the previous studies, the findings are for
the exclusive conditions of CWP or CFS, and thus the
effect of obesity can be investigated without the issue
of overlap between the 2 conditions potentially
affecting any association (or lack of association).
Strengths and Limitations
To the authors’ knowledge, this is the first study to
investigate differences in a range of covariates between
adolescents with exclusive CFS, exclusive CWP, or both
morbidities coexisting. One of the limitations of this
study is that the 3,214 adolescents included represent
only a minority of the approximately 14,000 mother-
child dyads who were originally enrolled in the study, re-
sulting in a selected study sample. For example,
compared with the complete cohort, those included in
the current study were more likely to have mothers
educated to at least degree level (20.3% vs 10.2%) and
who gave birth at a later age (29.4 years vs 27.5 years).
Nonetheless, we have no reason to believe that the asso-
ciation between pain and CFS differs according to
maternal age and/or educational status and thus we
doubt whether this would have influenced the results.
However, because of the relative infrequency of both
conditions, the number of participants with CFS together
with CWP provided a very small sample (n = 12) from
which to draw conclusions. The fact that the study was
questionnaire-based means that there is a possibility
that recall bias was introduced into the results. For
example, the strong association between depression
and CFS may influence the reporting of pain and its
severity. However, associations persisted after adjust-
ment for depression (Table 3). Furthermore, the retro-
spective nature of the questionnaire (relating to
experiences of pain experienced at least 3 months ago)
means that the passing of time could introduce further
bias into pain ratings. For example, it has been observed
that when retrospectively rating experiences of average
pain, recall is found to be a combination of ratings of
pain at its peak and at the end of the experience,
although the effect was small.28,57 A further limitation
is that because data on only 9 of the 12 symptoms
included in the NICE guideline could be collected using
the CIS-R, the estimates of CFS at 17 years may be under-
estimated. Finally, the sensitivity analysis of those with
only pain data versus those with complete data shows
we may have introduced some selection bias into our
sample, because the sample with only pain data did
show a higher proportion of adolescents reporting
more severe levels of pain on average, compared with
thosewith complete data, however there were no differ-
ences in the other pain ratings, fatigue, depression, and
anxiety.
Apart from sex, we do not know whether the associa-
tions we have described are causal or secondary to the
CFS and CWP,7 because these characteristics were all
collected at the same point in time (ie, a cross-sectional
study). Although longitudinal studies in children and ad-
olescents have suggested that the direction of causation
might be that anxiety and depression lead to fa-
tigue,58,64 it is uncertain whether this can be extended
to CFS.7 For example, a recent study in the same cohort
Norris et al The Journal of Pain 7
showed that after adjustment for maternal psychopa-
thology, childhood mood problems were not predictive
of CFS at 13 years.17
Because the pain questionnaire administered did not
include questions relating to areas of tenderness, we
were unable to classify adolescents as having fibromyal-
gia and are thus unable to draw any specific conclusions
about the relationship between CFS and fibromyalgia in
this population. Because CWP is the primary symptom of
fibromyalgia,38 it may however be speculated that
similar relationships may have been observed, had it
been possible to classify this condition. Nonetheless,
further research is required to identify whether the rela-
tionships observedwith CWP in this study aremaintained
in cases of fibromyalgia.
This study showed that 14.6% of adolescents with CFS
have comorbid CWP, and the likely greater proportion
ofmoremild cases observed in this epidemiological study
means that theprevalenceof overlap is likely tobeunder-
estimated compared with those attending specialist ser-
vices. Because severe pain is associated with a worse
outcome in adults,11,29 clinicians should be aware of the
overlap between these 2 conditions and should
carefully consider the treatment options offered.
Developing appropriate, targeted interventions for
children with CFS and chronic pain may increase the
likelihood of improved outcomes.
Conclusions
Future research should investigatewhether depression
and anxiety are causal or secondary to CFS and whether
anxiety is causal for chronic pain syndrome. Furthermore,
it is important to elucidate the factors that are contrib-
uting to the higher prevalence of CFS, and to a greater
degree, CWP, observed in women.
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